OX40L
Aliases: | CD134L, CD252, GP34, OX-40L, OX4OL, TNLG2B, TXGP1 |
---|---|
Other: | tumor necrosis factor ligand superfamily member 4|CD134 ligand|OX40 antigen ligand|glycoprotein Gp34|tax-transcriptionally activated glycoprotein 1 (34kD)|tumor necrosis factor (ligand) superfamily member 4|tumor necrosis factor ligand 2B|tumor necrosis factor superfamily member 4 |
This gene encodes a cytokine of the tumor necrosis factor (TNF) ligand family. The encoded protein functions in T cell antigen-presenting cell (APC) interactions and mediates adhesion of activated T cells to endothelial cells. Polymorphisms in this gene have been associated with Sjogren's syndrome and systemic lupus erythematosus. Alternative splicing results in multiple transcript variants. [p... see more
DyLight 350
Common Laser: | 355 |
---|---|
Common Filter: | 450/50 |
Excitation Peak: | 353 |
Emission Peak: | 432 |
DyLight™ 350 has an excitation peak of 353 nm and an emission peak of 432 nm. It is spectrally similar to Alexa Fluor™ 350, iFluor® 350, AMCA, and Thioflavin T. DyLight™ 350 is most commonly used in flow cytometery and fluorescence microscopy applications.
Popular OX40L DyLight 350 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
Novus Biologicals NBP2-11969UV |
FC,IHC,IHC-Fr | OX40L Human |
Mouse IgG1 MM0505-8S23 |
0.1 ml $518 |
Details | |
Novus Biologicals NBP2-75913UV |
FC | OX40L Human |
Human IgG1 κ R4930 (Oxelumab) |
0.1 ml $464 |
Details | |
NBP1-06683UV |
FC,IHC-Fr | OX40L Mouse |
Rat IgG2 AP-MAB0834 |
500 Tests $459 |
Details | |
NBP1-43353UV |
FC | OX40L Rat |
Mouse IgG1 κ ATM2 |
100 μl $369 |
Details | |
Novus Biologicals NBP2-52687UV |
FC | OX40L Human |
Rabbit IgG κ R4930 (Oxelumab) |
0.1 ml $485 |
Details | |
NB100-78085UV |
FC | OX40L Human |
Mouse IgG1 κ 11C3.1 |
100 μl $329 |
Details | |
Novus Biologicals FAB10541D |
FC,ICC | OX40L Human |
Mouse IgG1 159403 |
0.1 ml $539 |
Details | |
Browse OX40L / DyLight 350 antibodies. |